Sanofi Ventures describes itself as "the corporate venture capital arm of Sanofi" and states that it invests "across all stages of the private company lifecycle, from Seed to Series B and beyond" in "biotech and digital health companies". Its stated interest areas are rare diseases, immunology and inflammation, oncology, cell and gene therapy, vaccines, and digital health and data science. The firm says it offers portfolio companies "select access to Sanofi's expertise and capabilities in science, preclinical and clinical development, regulatory, data analytics, manufacturing, market access, and commercialization". Its team page describes its focus as "biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system". These are the firm's own claims. It operates from Cambridge, Massachusetts in the US and Paris, France in the EU.